Trial Outcomes & Findings for Saline vs. Lactated Ringers for Emergency Department IV Fluid Resuscitation (NCT NCT03133767)
NCT ID: NCT03133767
Last Updated: 2018-09-11
Results Overview
The Quality of Recovery-40 (QoR-40) is a validated instrument that quantifies patient's self-assessment of functional recovery, symptoms, and physical comfort. The QoR-40 scores range from 40 to 200 with a 200 representing a better recovery outcome. The survey consists of 40 questions scored from one to five with a Likert scale, and the total score is the sum of each question.
COMPLETED
PHASE4
157 participants
24 hours after ED visit
2018-09-11
Participant Flow
Participant milestones
| Measure |
Lactated Ringers Solution
Participants in this arm will receive two liters of IV Lactated Ringer's solution during their emergency department stay
Lactated Ringer Solution: 2 liters of intravenous lactated ringers solution will be administered by peripheral IV
|
Normal Saline Solution
Participants in this arm will receive two liters of IV 0.9% sodium chloride solution during their emergency department stay
Normal Saline 0.9% Infusion Solution Bag: 2 liters of intravenous normal saline solution will be administered by peripheral IV
|
|---|---|---|
|
Overall Study
STARTED
|
79
|
78
|
|
Overall Study
COMPLETED
|
41
|
53
|
|
Overall Study
NOT COMPLETED
|
38
|
25
|
Reasons for withdrawal
| Measure |
Lactated Ringers Solution
Participants in this arm will receive two liters of IV Lactated Ringer's solution during their emergency department stay
Lactated Ringer Solution: 2 liters of intravenous lactated ringers solution will be administered by peripheral IV
|
Normal Saline Solution
Participants in this arm will receive two liters of IV 0.9% sodium chloride solution during their emergency department stay
Normal Saline 0.9% Infusion Solution Bag: 2 liters of intravenous normal saline solution will be administered by peripheral IV
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
38
|
24
|
|
Overall Study
Protocol Violation
|
0
|
1
|
Baseline Characteristics
Saline vs. Lactated Ringers for Emergency Department IV Fluid Resuscitation
Baseline characteristics by cohort
| Measure |
Lactated Ringers Solution
n=41 Participants
Participants in this arm will receive two liters of IV Lactated Ringer's solution during their emergency department stay
Lactated Ringer Solution: 2 liters of intravenous lactated ringers solution will be administered by peripheral IV
|
Normal Saline Solution
n=53 Participants
Participants in this arm will receive two liters of IV 0.9% sodium chloride solution during their emergency department stay
Normal Saline 0.9% Infusion Solution Bag: 2 liters of intravenous normal saline solution will be administered by peripheral IV
|
Total
n=94 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
29 years
n=93 Participants
|
39 years
n=4 Participants
|
35 years
n=27 Participants
|
|
Sex: Female, Male
Female
|
34 Participants
n=93 Participants
|
24 Participants
n=4 Participants
|
58 Participants
n=27 Participants
|
|
Sex: Female, Male
Male
|
7 Participants
n=93 Participants
|
29 Participants
n=4 Participants
|
36 Participants
n=27 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
|
Race (NIH/OMB)
Asian
|
3 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
3 Participants
n=27 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
|
Race (NIH/OMB)
Black or African American
|
2 Participants
n=93 Participants
|
7 Participants
n=4 Participants
|
9 Participants
n=27 Participants
|
|
Race (NIH/OMB)
White
|
34 Participants
n=93 Participants
|
45 Participants
n=4 Participants
|
79 Participants
n=27 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=93 Participants
|
0 Participants
n=4 Participants
|
0 Participants
n=27 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
2 Participants
n=93 Participants
|
1 Participants
n=4 Participants
|
3 Participants
n=27 Participants
|
|
Region of Enrollment
United States
|
41 participants
n=93 Participants
|
53 participants
n=4 Participants
|
94 participants
n=27 Participants
|
PRIMARY outcome
Timeframe: 24 hours after ED visitThe Quality of Recovery-40 (QoR-40) is a validated instrument that quantifies patient's self-assessment of functional recovery, symptoms, and physical comfort. The QoR-40 scores range from 40 to 200 with a 200 representing a better recovery outcome. The survey consists of 40 questions scored from one to five with a Likert scale, and the total score is the sum of each question.
Outcome measures
| Measure |
Normal Saline Solution
n=53 Participants
Participants in this arm will receive two liters of IV 0.9% sodium chloride solution during their emergency department stay
Normal Saline 0.9% Infusion Solution Bag: 2 liters of intravenous normal saline solution will be administered by peripheral IV
|
Lactated Ringers Solution
n=41 Participants
Participants in this arm will receive two liters of IV Lactated Ringer's solution during their emergency department stay
Lactated Ringer Solution: 2 liters of intravenous lactated ringers solution will be administered by peripheral IV
|
|---|---|---|
|
Quality of Recovery-40 Score at 24 Hours
|
164.4 units on a scale
Interval 157.8 to 171.0
|
166.8 units on a scale
Interval 160.5 to 173.1
|
SECONDARY outcome
Timeframe: Immediately after fluid administrationThe Quality of Recovery-40 (QoR-40) is a validated instrument that quantifies patient's self-assessment of functional recovery, symptoms, and physical comfort. The QoR-40 scores range from 40 to 200 with a 200 representing a better recovery outcome. The survey consists of 40 questions scored from one to five with a Likert scale, and the total score is the sum of each question.
Outcome measures
| Measure |
Normal Saline Solution
n=53 Participants
Participants in this arm will receive two liters of IV 0.9% sodium chloride solution during their emergency department stay
Normal Saline 0.9% Infusion Solution Bag: 2 liters of intravenous normal saline solution will be administered by peripheral IV
|
Lactated Ringers Solution
n=41 Participants
Participants in this arm will receive two liters of IV Lactated Ringer's solution during their emergency department stay
Lactated Ringer Solution: 2 liters of intravenous lactated ringers solution will be administered by peripheral IV
|
|---|---|---|
|
Quality of Recovery-40 Score After Administration
|
141.6 units on a scale
Interval 133.5 to 149.7
|
152.6 units on a scale
Interval 145.3 to 159.9
|
SECONDARY outcome
Timeframe: 7 days after study enrollmentPopulation: Only participants that received an ED prescription and responded to the seven-day text message were included in this analysis (26 participants in the LR and 25 in the NS group).
Seven days after study enrollment, participants were asked by text message, "Have you filled any prescriptions from the emergency department?"
Outcome measures
| Measure |
Normal Saline Solution
n=25 Participants
Participants in this arm will receive two liters of IV 0.9% sodium chloride solution during their emergency department stay
Normal Saline 0.9% Infusion Solution Bag: 2 liters of intravenous normal saline solution will be administered by peripheral IV
|
Lactated Ringers Solution
n=26 Participants
Participants in this arm will receive two liters of IV Lactated Ringer's solution during their emergency department stay
Lactated Ringer Solution: 2 liters of intravenous lactated ringers solution will be administered by peripheral IV
|
|---|---|---|
|
Number of Participants That Filled an ED Prescription
|
19 Participants
|
14 Participants
|
SECONDARY outcome
Timeframe: 7 daysPopulation: Response rates for the secondary outcomes were 47.4% (n=36) in the NS group and 53.3% (n=42) in the LR group.
Seven days after study enrollment, participants were asked by text message, "Have you returned to the emergency department for the same problem?"
Outcome measures
| Measure |
Normal Saline Solution
n=36 Participants
Participants in this arm will receive two liters of IV 0.9% sodium chloride solution during their emergency department stay
Normal Saline 0.9% Infusion Solution Bag: 2 liters of intravenous normal saline solution will be administered by peripheral IV
|
Lactated Ringers Solution
n=42 Participants
Participants in this arm will receive two liters of IV Lactated Ringer's solution during their emergency department stay
Lactated Ringer Solution: 2 liters of intravenous lactated ringers solution will be administered by peripheral IV
|
|---|---|---|
|
Number of Participants That Returned to the ED Within 7 Days for the Same Complaint
|
7 Participants
|
5 Participants
|
SECONDARY outcome
Timeframe: 7 daysPopulation: Response rates for the secondary outcomes were 47.4% (n=36) in the NS group and 53.3% (n=42) in the LR group.
Seven days after study enrollment, participants were asked by text message, "Have you seen another medical provider for the same complaint?".
Outcome measures
| Measure |
Normal Saline Solution
n=36 Participants
Participants in this arm will receive two liters of IV 0.9% sodium chloride solution during their emergency department stay
Normal Saline 0.9% Infusion Solution Bag: 2 liters of intravenous normal saline solution will be administered by peripheral IV
|
Lactated Ringers Solution
n=42 Participants
Participants in this arm will receive two liters of IV Lactated Ringer's solution during their emergency department stay
Lactated Ringer Solution: 2 liters of intravenous lactated ringers solution will be administered by peripheral IV
|
|---|---|---|
|
Participants That Sought Care From Another Healthcare Provider for the Same Complaint
|
7 Participants
|
9 Participants
|
Adverse Events
Lactated Ringers Solution
Normal Saline Solution
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place